Detalhe da pesquisa
1.
The European Genome-phenome Archive in 2021.
Nucleic Acids Res;
50(D1): D980-D987, 2022 01 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34791407
2.
Transcriptome-wide association study of breast cancer risk by estrogen-receptor status.
Genet Epidemiol;
44(5): 442-468, 2020 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32115800
3.
The predictive ability of the 313 variant-based polygenic risk score for contralateral breast cancer risk prediction in women of European ancestry with a heterozygous BRCA1 or BRCA2 pathogenic variant.
Genet Med;
23(9): 1726-1737, 2021 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34113011
4.
Oral contraceptive use and ovarian cancer risk for BRCA1/2 mutation carriers: an international cohort study.
Am J Obstet Gynecol;
225(1): 51.e1-51.e17, 2021 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33493488
5.
Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriers.
Breast Cancer Res;
22(1): 8, 2020 01 16.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31948486
6.
Correction to: Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriers.
Breast Cancer Res;
22(1): 25, 2020 Feb 26.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32102695
7.
Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants.
Genet Med;
22(10): 1653-1666, 2020 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32665703
8.
Mendelian randomisation study of height and body mass index as modifiers of ovarian cancer risk in 22,588 BRCA1 and BRCA2 mutation carriers.
Br J Cancer;
121(2): 180-192, 2019 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31213659
9.
Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations.
Hum Mutat;
39(5): 593-620, 2018 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29446198
10.
Risks of breast or ovarian cancer in BRCA1 or BRCA2 predictive test negatives: findings from the EMBRACE study.
Genet Med;
20(12): 1575-1582, 2018 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29565421
11.
Breast-cancer risk in families with mutations in PALB2.
N Engl J Med;
371(6): 497-506, 2014 Aug 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25099575
12.
Association of breast cancer risk in BRCA1 and BRCA2 mutation carriers with genetic variants showing differential allelic expression: identification of a modifier of breast cancer risk at locus 11q22.3.
Breast Cancer Res Treat;
161(1): 117-134, 2017 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27796716
13.
Breast cancer risk prediction using a polygenic risk score in the familial setting: a prospective study from the Breast Cancer Family Registry and kConFab.
Genet Med;
19(1): 30-35, 2017 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27171545
14.
DNA glycosylases involved in base excision repair may be associated with cancer risk in BRCA1 and BRCA2 mutation carriers.
PLoS Genet;
10(4): e1004256, 2014 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24698998
15.
Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers.
JAMA;
317(23): 2402-2416, 2017 06 20.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28632866
16.
Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2.
Breast Cancer Res;
18(1): 15, 2016 Feb 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26857456
17.
Inheritance of deleterious mutations at both BRCA1 and BRCA2 in an international sample of 32,295 women.
Breast Cancer Res;
18(1): 112, 2016 11 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27836010
18.
Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus.
Breast Cancer Res;
18(1): 64, 2016 06 21.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27459855
19.
No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.
Gynecol Oncol;
141(2): 386-401, 2016 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25940428
20.
Identification of a BRCA2-specific modifier locus at 6p24 related to breast cancer risk.
PLoS Genet;
9(3): e1003173, 2013.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23544012